Skip to main content
Figure 2 | Malaria Journal

Figure 2

From: The impact of lipid-based nutrient supplementation on anti-malarial antibodies in pregnant women in a randomized controlled trial

Figure 2

Antibodies to malaria antigens at 36 weeks categorized by supplementation type. (A) Antibodies to variant surface antigens expressed by placental-binding and non-placental-binding parasite isolates. (B) Antibodies to merozoite antigens and schizont extract. Data presented as box plots with the Y axis representing antibodies as a percentage of the positive control. The whiskers denote the 10th and the 90th percentiles with outliers. Mann Whitney U test performed for antibody comparisons between supplementation groups LNS versus IFA and LNS versus MMN. Nā€‰=ā€‰1,009.

Back to article page